- |||||||||| lerapolturev (PVS-RIPO) / Istari Oncology
Enrollment change, Trial primary completion date: PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) - Nov 15, 2015
P1, N=65, Recruiting,
N=32 --> 65 | Trial primary completion date: Jan 2016 --> Jan 2017
- |||||||||| lerapolturev (PVS-RIPO) / Istari Oncology
Trial primary completion date: PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) - Jan 18, 2015
P1, N=32, Recruiting,
N=32 --> 65 | Trial primary completion date: Jan 2016 --> Jan 2017 Trial primary completion date: Jan 2015 --> Jan 2016
- |||||||||| lerapolturev (PVS-RIPO) / Istari Oncology
Enrollment change: PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) - Aug 22, 2014
P1, N=32, Recruiting,
Trial primary completion date: Jan 2015 --> Jan 2016 N=18 --> 32
- |||||||||| lerapolturev (PVS-RIPO) / Istari Oncology
Enrollment open: PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) - Aug 28, 2013
P1, N=18, Recruiting,
N=18 --> 32 Suspended --> Recruiting
|
